Abstract
2375P Neoadjuvant sintilimab combined with gemcitabine and cisplatin (GP) for muscle-invasive bladder cancer (MIBC) patients followed by selective bladder sparing surgery
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have